INZY — Inozyme Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for Inozyme Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	148	112	128	189	113
Net Total Receivables	0.155	0.062	0.115	0.385	0.467
Prepaid Expenses
Total Other Current Assets
Total Current Assets	151	115	131	196	121
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.65	4.44	3.64	2.59	1.35
Long Term Investments
Other Long Term Assets
Total Assets	169	124	139	201	123
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	9.97	11.6	14.7	14.7	33.9
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	11.3	14.3	20.8	60.4	65.4
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	158	109	118	140	57.8
Total Liabilities & Shareholders' Equity	169	124	139	201	123
Total Common Shares Outstanding